Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2017

M Janjua B, Ivasyk I, Pisapia DJ, Souweidane MM. Ganglioglioma of brain stem and cervicomedullary junction: A 50years review of literature. J Clin Neurosci. 2017;44:34-46.

Nguyen DP, O'Malley P, Awamlh BA, Furrer M-, Mongan NP, Robinson BD, et al. Association of Aromatase With Bladder Cancer Stage and Long-Term Survival: New Insights Into the Hormonal Paradigm in Bladder Cancer. Clin Genitourin Cancer. 2017;15(2):256-262.e1.

Büchel G, Carstensen A, Mak K-, Roeschert I, Leen E, Sumara O, et al. Association with Aurora-A Controls N-MYC-Dependent Promoter Escape and Pause Release of RNA Polymerase II during the Cell Cycle. Cell Rep. 2017;21(12):3483-3497.

Gullett JC, Westblade LF, Green DA, Whittier S, Burd EM. The Brief Case: Too Beta To Be a "B". J Clin Microbiol. 2017;55(6):1604-1607.

Iyengar NM, Brown KA, Zhou XK, Gucalp A, Subbaramaiah K, Giri DD, et al. Metabolic Obesity, Adipose Inflammation and Elevated Breast Aromatase in Women with Normal Body Mass Index. Cancer Prev Res (Phila). 2017;10(4):235-243.

Gong Q, Wang C, Zhang W, Iqbal J, Hu Y, Greiner TC, et al. Assessment of T-cell receptor repertoire and clonal expansion in peripheral T-cell lymphoma using RNA-seq data. Sci Rep. 2017;7(1):11301.

Loupy A, Haas M, Solez K, Racusen L, Glotz D, Seron D, et al. The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology. Am J Transplant. 2017;17(1):28-41.

Wang P, Byrum S, Fowler FC, Pal S, Tackett AJ, Tyler JK. Proteomic identification of histone post-translational modifications and proteins enriched at a DNA double-strand break. Nucleic Acids Res. 2017;45(19):10923-10940.

Panarelli NC, Gobara N, Hoda RS, Chaump M, Jessurun J, Yantiss RK. Cytology Preparations of Formalin Fixative Aid Detection of Giardia in Duodenal Biopsy Samples. Am J Surg Pathol. 2017;41(4):570-574.

Aukes K, Forsman C, Brady NJ, Astleford K, Blixt N, Sachdev D, et al. Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions. PLoS One. 2017;12(10):e0185736.